Medline Inc. (MDLN) FY2026 Q1 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-01-01 to 2026-03-28

Swipe to see the full flow
Medline Inc. cash flow reconciliation, Jan 1, 2026 through Mar 28, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Depreciation and amortization → operating reconciliation: $254,000,000.00Net income → operating reconciliation: $239,000,000.00Accrued expenses and other current liabilities → operating reconciliation: $72,000,000.00Deferred taxes → operating reconciliation: $37,000,000.00Stock-based compensation expense → operating reconciliation: $23,000,000.00Non-cash lease expense → operating reconciliation: $17,000,000.00Amortization of deferred financing costs → operating reconciliation: $11,000,000.00Accounts payable → operating reconciliation: $6,000,000.00Other non-cash adjustments → operating reconciliation: $3,000,000.00Credit losses → operating reconciliation: $1,000,000.00operating reconciliation → Net cash from operating activities: $412,000,000.00operating reconciliation → Trade accounts receivable: $146,000,000.00operating reconciliation → Inventories: $42,000,000.00operating reconciliation → Other liabilities: $32,000,000.00operating reconciliation → Other assets: $19,000,000.00operating reconciliation → Unrealized foreign exchange (gain) loss, net: $12,000,000.00Net cash used in investing activities → investing reconciliation: $96,000,000.00investing reconciliation → Purchases of property and equipment, net: $96,000,000.00Net cash used in financing activities → financing reconciliation: $13,000,000.00financing reconciliation → Distributions to noncontrolling interests: $10,000,000.00financing reconciliation → Payment for offering costs: $3,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $1,942,000,000.00Net cash from operating activities → Cash sources and uses: $412,000,000.00Cash sources and uses → Exchange-rate effect: $7,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $2,238,000,000.00Cash sources and uses → Net cash used in investing activities: $96,000,000.00Cash sources and uses → Net cash used in financing activities: $13,000,000.00Net income: $239,000,000.00Net income+$239.00 MDepreciation and amortization: $254,000,000.00Depreciation & amortization+$254.00 MStock-based compensation expense: $23,000,000.00Stock-based compensation+$23.00 MAmortization of deferred financing costs: $11,000,000.00Debt issuance cost amortization+$11.00 MCredit losses: $1,000,000.00Credit loss provision+$1.00 MUnrealized foreign exchange (gain) loss, net: -$12,000,000.00Unrealized FX gain & loss−$12.00 MNon-cash lease expense: $17,000,000.00Non-cash lease expense+$17.00 MOther non-cash adjustments: $3,000,000.00Other non-cash items+$3.00 MTrade accounts receivable: -$146,000,000.00Accounts receivable−$146.00 MInventories: -$42,000,000.00Inventories−$42.00 MOther assets: -$19,000,000.00Other operating assets−$19.00 MAccounts payable: $6,000,000.00Accounts payable+$6.00 MAccrued expenses and other current liabilities: $72,000,000.00Accrued liabilities+$72.00 MOther liabilities: -$32,000,000.00Other operating liabilities−$32.00 MDeferred taxes: $37,000,000.00Deferred income taxes+$37.00 MNet cash from operating activities: $412,000,000.00Operating cash+$412.00 Moperating reconciliation: $663,000,000.00Payment for offering costs: -$3,000,000.00Stock issuance costs−$3.00 MRepayments under lines of credit: $0.00Proceeds from lines of credit: $0.00Payment towards Class B unit repurchases: $0.00Distributions to noncontrolling interests: -$10,000,000.00Paid to noncontrolling interests−$10.00 MNet cash used in financing activities: -$13,000,000.00. Cash required to fund net payments.Financing cash−$13.00 Mfinancing reconciliation: $13,000,000.00Purchases of property and equipment, net: -$96,000,000.00PP&E purchases−$96.00 MAcquisitions of businesses, net of cash acquired: $0.00Net cash used in investing activities: -$96,000,000.00. Cash required to fund net payments.Investing cash−$96.00 Minvesting reconciliation: $96,000,000.00Cash sources and uses: $2,354,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $1,942,000,000.00Beginning cash$1.94 BEnding cash: Cash, cash equivalents, and restricted cash: $2,238,000,000.00Ending cash$2.24 BExchange-rate effect: -$7,000,000.00FX effect−$7.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$316.00 MOperating cash − cash spent on PP&ECash flow / Net incomeUnavailableOperating cash flow ÷ net incomeNet cash change+$296.00 MEnding cash − beginning cash
Chart details

Medline Inc. cash flow reconciliation, Jan 1, 2026 through Mar 28, 2026

Cash flows for Jan 1, 2026 through Mar 28, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Mar 28, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
1,942,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
412,000,000 US dollars. Net cash provided.
Net income
239,000,000 US dollars
Depreciation and amortization
254,000,000 US dollars
Stock-based compensation expense
23,000,000 US dollars
Amortization of deferred financing costs
11,000,000 US dollars
Credit losses
1,000,000 US dollars
Unrealized foreign exchange (gain) loss, net
negative 12,000,000 US dollars
Non-cash lease expense
17,000,000 US dollars
Other non-cash adjustments
3,000,000 US dollars
Trade accounts receivable
negative 146,000,000 US dollars
Inventories
negative 42,000,000 US dollars
Other assets
negative 19,000,000 US dollars
Accounts payable
6,000,000 US dollars
Accrued expenses and other current liabilities
72,000,000 US dollars
Other liabilities
negative 32,000,000 US dollars
Deferred taxes
37,000,000 US dollars
Investing activities
negative 96,000,000 US dollars. Net cash used.
Purchases of property and equipment, net
negative 96,000,000 US dollars
Acquisitions of businesses, net of cash acquired
0 US dollars
Financing activities
negative 13,000,000 US dollars. Net cash used.
Payment for offering costs
negative 3,000,000 US dollars
Repayments under lines of credit
0 US dollars
Proceeds from lines of credit
0 US dollars
Payment towards Class B unit repurchases
0 US dollars
Distributions to noncontrolling interests
negative 10,000,000 US dollars
Operating adjustment reconciliation
663,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
13,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
96,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 7,000,000 US dollars
Ending cash on Mar 28, 2026
2,238,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
2,354,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
296,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Unavailable. Operating cash flow and reconciliation net income for the same period are required.
Operating cash flow
412,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
96,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
316,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 412,000,000 US dollars minus 96,000,000 US dollars equals 316,000,000 US dollars.
Medline Inc. (MDLN) FY2026 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!